1. Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue
- Author
-
Tore Bengtsson, Bronwyn A Evans, Saori Mukaida, Masaaki Sato, Dana S. Hutchinson, and Ling Yeong Chia
- Subjects
0301 basic medicine ,Adipose tissue ,mTORC1 ,mTORC2 ,Themed Section: Review Articles ,Muscle hypertrophy ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Animals ,Humans ,Muscle, Skeletal ,Mechanistic target of rapamycin ,PI3K/AKT/mTOR pathway ,Pharmacology ,Sirolimus ,biology ,Skeletal muscle ,Adrenergic beta-Agonists ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,Adipose Tissue ,biology.protein ,030217 neurology & neurosurgery ,GLUT4 - Abstract
A vital role of adrenoceptors in metabolism and energy balance has been well documented in the heart, skeletal muscle, and adipose tissue. It has been only recently demonstrated, however, that activation of the mechanistic target of rapamycin (mTOR) makes a significant contribution to various metabolic and physiological responses to adrenoceptor agonists. mTOR exists as two distinct complexes named mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) and has been shown to play a critical role in protein synthesis, cell proliferation, hypertrophy, mitochondrial function, and glucose uptake. This review will describe the physiological significance of mTORC1 and 2 as a novel paradigm of adrenoceptor signalling in the heart, skeletal muscle, and adipose tissue. Understanding the detailed signalling cascades of adrenoceptors and how they regulate physiological responses is important for identifying new therapeutic targets and identifying novel therapeutic interventions. LINKED ARTICLES: This article is part of a themed section on Adrenoceptors-New Roles for Old Players. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.14/issuetoc.
- Published
- 2018